| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/15/2009 | EP2048143A1 Prodrug of cinnamide compound |
| 04/15/2009 | EP2048142A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
| 04/15/2009 | EP2047864A1 Use of rpn2 gene expression inhibitor |
| 04/15/2009 | EP2047859A1 Treatment of ischemic disease using erythropoietin |
| 04/15/2009 | EP2047848A1 Method of treating genetic disease caused by nonsense mutation |
| 04/15/2009 | EP2047845A1 Adhesive preparation |
| 04/15/2009 | EP2047844A2 A method of microencapsulation |
| 04/15/2009 | EP2046834A1 Monoclonal antibodies against stromal derived factor-1 (sdf-1) |
| 04/15/2009 | EP2046727A1 Positively charged water-soluble prodrugs of diclofenac with very fast skin penetration rate |
| 04/15/2009 | EP2046340A2 Jak inhibitors for treatment of myeloproliferative disorders |
| 04/15/2009 | EP2046311A2 Dioxo-alkanes and dioxo-alkenes |
| 04/15/2009 | EP2003130A9 Novel pyridine derivative having anti-helicobacter pylori activity |
| 04/15/2009 | EP1797881B1 Medicinal composition with improved stability and reduced gelation properties |
| 04/15/2009 | EP1719773B1 Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor |
| 04/15/2009 | EP1551763B1 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 04/15/2009 | EP1423115B1 Antiangiogenic activity of nitrogen substituted thalidomide analogs |
| 04/15/2009 | EP1419143B1 24-sulfur-substituted analogs of 1alpha,25-dihydroxy vitamin d3 |
| 04/15/2009 | EP1417307B1 Oligonucleotide compositions and their use to induce apoptosis |
| 04/15/2009 | EP1399109B1 Separation of platelets from whole blood for use as wound healants |
| 04/15/2009 | EP1378246B1 sPLA2 INHIBITORS FOR ARTERIOSCLEROSIS |
| 04/15/2009 | EP1363635B1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 04/15/2009 | EP1311532B1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 04/15/2009 | EP1267882B1 Prostaglandins for the treatment of eye disease caused by light irradiation like photoretinitis |
| 04/15/2009 | EP1244648B1 Chemokine receptor binding heterocyclic compounds |
| 04/15/2009 | EP1079854B1 Compositions and methods of modulating an immune response to an antigen by administration of cytokine-coated cells |
| 04/15/2009 | CN101410124A Thioredoxin production promoting agent |
| 04/15/2009 | CN101407796A Recombinant alpha-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 04/15/2009 | CN101407782A Oral DNA vaccine for promoting growth of animal by non-antibiotics resistance gene screening, and preparation and use thereof |
| 04/15/2009 | CN101407781A Inhibin DNA vaccine capable of improving animal fertility, and preparation and use thereof |
| 04/15/2009 | CN101407546A Human anti-human tumor necrosis factor-alpha single chain antibody |
| 04/15/2009 | CN101407539A Oligopeptide having marrow hemopoiesis protection function, preparation thereof, pharmaceutical composition containing the oligopeptide and use |
| 04/15/2009 | CN101407471A Compound capable of binding S1P receptor and pharmaceutical use thereof |
| 04/15/2009 | CN101407457A Carboxyl substituted chalcone derivative, preparation and use |
| 04/15/2009 | CN101406682A Method for producing plaster for dispelling children's tetanus neonatorium in six hours |
| 04/15/2009 | CN101406654A Oral liquid for treating hoove |
| 04/15/2009 | CN101406551A Method for producing agent for treating cold hands and feet |
| 04/15/2009 | CN101406489A Micro-ecological complex bacterial agent and method of preparing micro-ecological complex bacterial agent |
| 04/15/2009 | CN101406482A Composition for preventing and treating crustacean disease |
| 04/15/2009 | CN101406475A Use of lapatinib for reversing multi-drug resistance of tumor |
| 04/15/2009 | CN101406473A Use of dihydropyrimidine compound and pharmaceutical composition containing the same |
| 04/15/2009 | CN101406471A Novel heterocyclic compounds which are active as inhibitors of beta-lactamases |
| 04/15/2009 | CN101406470A Use of heterocyclic ring derivative of pyridine and pharmaceutical composition containing the same |
| 04/15/2009 | CN101406469A Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 04/15/2009 | CN101406468A Use of benzofuryl derivative and pharmaceutical composition containing the same |
| 04/15/2009 | CN101406465A Combination of a serotonin reuptake inhibitor and a 5-HT2C antagonist, inverse agonist or partial agonist |
| 04/15/2009 | CN101406459A Chinese paris rhizome total saponin dispersible tablet and technique of preparing the same |
| 04/15/2009 | CN101406457A Process for the manufacture of a pharmaceutical product |
| 04/15/2009 | CN101406453A Pharmaceutical compositions for oral and topical administration |
| 04/15/2009 | CN101406448A Percutaneous breast health-care powder |
| 04/15/2009 | CN100478032C Preparation method of injection type pH and glucose sensitive hydrogel |
| 04/15/2009 | CN100478031C The use of substituted tetracyclic imidazole derivatives as anti-histaminics |
| 04/15/2009 | CN100478029C Immunomodulatory human MHC class II antigen-binding polypeptides |
| 04/15/2009 | CN100478005C Medicinal substance for antibrain senile extracted from schisandra |
| 04/15/2009 | CN100477992C Substituted piperazine and piperidine calcium channel blockers |
| 04/14/2009 | US7517996 methyl 3-(4-{4-[1-(2-chlorophenyl)ethoxycarbonylamino]-3-isoxazolyl}-benzylsulfanyl)propionate; compounds inhibit the physiological activity of lysophosphatidic acid (LPA); treatment of fibrosis of organs (liver, kidney, lung, and the like), hepatic disease |
| 04/14/2009 | US7517989 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/14/2009 | US7517971 Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity |
| 04/14/2009 | US7517953 With low peroxide and anisidine values and high polyunsaturated fatty acid content; heating from 40 to 70 degrees C at a rate of 1 degree per minute, a plateau stage, cooling at the same rate; improved electrical efficency; baby formula |
| 04/14/2009 | US7517910 Alkoxyphenylpropanoic acid derivatives |
| 04/14/2009 | US7517892 Ligands for monoamine receptors and transporters, and methods of use thereof |
| 04/14/2009 | US7517883 Solubilized topoisomerase poisons |
| 04/14/2009 | US7517879 Pyrrolidine derivatives as factor Xa inhibitors |
| 04/14/2009 | US7517875 Piperidine derivatives having CCR3 antagonism |
| 04/14/2009 | US7517861 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis |
| 04/14/2009 | US7517672 Nucleic acids encoding mammalian T-type calcium channels |
| 04/14/2009 | US7517669 Increasing the intracellular amount of at least one ferritin-H or a derivative to an effective level for suppressing disease caused or enhanced by effects of intracellular iron mismanagement |
| 04/14/2009 | US7517658 Drug screening for human SNORF33 receptor agonist by contacting cells transfected with and expressing DNA encoding the human SNORF33 receptor, wherein cells prior to being transfected with the DNA do not express the human SNORF33 receptor; inflammation, infections, arthritis; autoimmune diseases |
| 04/14/2009 | US7517535 Agonists and antagonists of nicotinergic acetylcholine receptors of insects like fleas, lice and flies, on humans or animals; chloronicotinyl insecticides such as imidaclopridas veterinary medicine; collars; tags |
| 04/14/2009 | US7517526 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 04/14/2009 | US7517525 Methods of inhibiting amyloid toxicity |
| 04/14/2009 | US7517523 Anti-MIF antibodies |
| 04/14/2009 | US7517517 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 04/14/2009 | CA2427817C Estrone-derivatives having cytoprotective activity |
| 04/14/2009 | CA2412213C A method for treating septic shock |
| 04/14/2009 | CA2409841C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/14/2009 | CA2408934C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/14/2009 | CA2396865C Farnesyl protein transferase inhibitors for treating breast cancer |
| 04/14/2009 | CA2387844C Treatment of emphysema using rar selective retinoid antagonists |
| 04/14/2009 | CA2386190C Regulators of the hedgehog pathway, compositions and uses related thereto |
| 04/14/2009 | CA2385863C New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 04/14/2009 | CA2371789C Novel guanidine derivatives as inhibitors of cell adhesion |
| 04/14/2009 | CA2348871C Multiparticulate modified release composition |
| 04/14/2009 | CA2337797C Naaladase inhibitors useful as pharmaceutical compounds and compositions |
| 04/14/2009 | CA2279198C Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent |
| 04/14/2009 | CA2256007C Substituted heterocyclic benzocycloalkenes and their use as analgesic |
| 04/14/2009 | CA2253211C Sulfonamide-substituted fused 5-membered ring compounds, their use as a medicament, and pharmaceutical preparations comprising them |
| 04/14/2009 | CA2237582C Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors |
| 04/14/2009 | CA2234231C Stabilizing formulation for ngf |
| 04/14/2009 | CA2232378C Aerosol compositions |
| 04/09/2009 | WO2009044930A1 Pharmaceutical composition for inhibiting the accumulation of amyloid-β protein |
| 04/09/2009 | WO2009044899A1 Nucleic acid capable of regulating the proliferation of cell |
| 04/09/2009 | WO2009044895A1 Composition inhibiting the expression of target gene |
| 04/09/2009 | WO2009044788A1 Benzoxazinone derivative |
| 04/09/2009 | WO2009044774A1 Remedy for graft-versus-host disease comprising interleukin-6 receptor inhibitor as the active ingredient |
| 04/09/2009 | WO2009044547A1 Nerve cell death inhibitor |
| 04/09/2009 | WO2009005551A3 Transcription factor modulating compounds and methods of use thereof |
| 04/09/2009 | US20090093669 Magnetophoresis apparatus and method of use |
| 04/09/2009 | US20090093639 Prodrugs of carbamate inhibitors of IMPDH |
| 04/09/2009 | US20090093617 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 04/09/2009 | US20090093546 Method and Pharmaceutical Compositions for Treatment of Anti-Estrogen Resistant Breast Cancer Using RXR Modulators |